[Lab] QYB orfo — Medutest came back 99.3% against a claimed 99.0%
Short version of the title, which is already short: QYB orfo — Medutest came back 99.3% against a claimed 99.0%. Longer version underneath. Numbers, in the order they matter: 99.3% and 99.0%. The analytical point, which this board keeps getting wrong by importing habits from the peptide side. For a peptide, purity is…
Daily rather than weekly sounds trivial until you think about what a missed dose means in each case.
nothing containing this is approved anywhere and research material is not for human use
identity testing on a small molecule is a different analytical problem
Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one.
I would not assume the tolerability profile transfers exactly. Similar class effects, different exposure profile.
nothing containing this is approved anywhere yet
Agreed — non-peptide is the fact that everything else follows from, including the manufacturing and the analytics.
oral and non-peptide is the whole engineering story
That is a phase 2 result being quoted as though the programme had reported.